Please login to the form below

Not currently logged in
Email:
Password:

priority access

This page shows the latest priority access news and features for those working in and with pharma, biotech and healthcare.

Amgen gets prevention claim for cholesterol drug Repatha

Amgen gets prevention claim for cholesterol drug Repatha

Amgen CEO Robert Bradway said a few weeks ago that “improving patient access to Repatha remains a top priority for our team”, adding that the cardiovascular outcomes data will be a ... With this approval, it's now more important than ever that

Latest news

  • GSK tops Access to Medicines Index for fifth time running GSK tops Access to Medicines Index for fifth time running

    Only 5% of products covered by pricing strategies currently meet affordability criteria in priority access countries, according to the 2016 Index, despite companies increasingly waiving patent rights in priority regions. ... The Access to Medicines Index

  • Ready for takeoff? Ready for takeoff?

    The most popular of the early access options is the Adaptive Pathway Pilot Programme, a precursor to PRIME. ... All sectors within the pharmaceutical industry will benefit from greater access to innovative new medicines across the EU.

  • AstraZeneca embarks on oncology research access project AstraZeneca embarks on oncology research access project

    AstraZeneca embarks on oncology research access project. Invites companies to join molecular data resource consortium. ... Contributors will benefit from early access to the resource and any additional tools developed, as well as priority access with

  • Cell Therapy licenses heart failure therapy in Japan Cell Therapy licenses heart failure therapy in Japan

    The accelerated regulatory pathway for regenerative medicines in Japan enables faster patient access, making it a natural priority for us," said Reginald, adding that having Daiichi Sankyo on board will allow

  • Look who’s talking (2.0): How technology is shaping healthcare communications Look who’s talking (2.0): How technology is shaping healthcare communications

    Dialogue is not restricted to HCPs and patients. With market access a priority for global pharma, payers are now increasingly influential and healthcare communications must engage them. ... Market access and communications functions still have some way

More from news
Approximately 1 fully matching, plus 10 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • OUTiCO Case Study - Product Launch

    CHALLENGE. New product launch. Limited market access capabilities in priority CCG/Health Boards. ... Short time frame to gain positive formulary positioning. SOLUTION. OUTiCO intelligence used to prioritise key customer targets across 25 priority

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics